Intervention-related body shame and wellness in persons at risk for Type 2 diabetes; iACT + diabetes prevention education vs. education alone. N=298. Lipsett, M., & Berkman, E. (2025). A randomized controlled trial of an acceptance and commitment therapy-informed diabetes prevention program reduces
Overview
This randomized controlled trial examines the effects of an acceptance and commitment therapy-informed diabetes prevention program compared to education alone on body shame and distress in individuals at risk for Type 2 diabetes. The study includes a sample size of 298 participants and was published in Health Psychology by Lipsett and Berkman in 2025.
- ID
a2eb8cc09ddf4e1f- Source org
- ACBS
- Author
- M. B. Lipsett (Center for Neurosciences), Elliot T. Berkman (Center for Neurosciences)
- Published
- 2025-04-15
- OA status
- green
- DOI
- 10.1037/hea0001434
- PMID
- Not recorded
- PMCID
- Not recorded
- Citations
- 3
Tags
Verification
- identityok via crossref · score 0.9 · checked_at unknown
- legitimacykeep via unknown · score 1 · checked_at unknown
- linkok via http-check · 2026-07-21T15:41:41.820142+00:00
Cite this entry
BibTeX
@article{allodium:a2eb8cc09ddf4e1f,
title = {Intervention-related body shame and wellness in persons at risk for Type 2 diabetes; iACT + diabetes prevention education vs. education alone. N=298. Lipsett, M., \& Berkman, E. (2025). A randomized controlled trial of an acceptance and commitment therapy-informed diabetes prevention program reduces },
author = {M. B. Lipsett and Elliot T. Berkman},
year = {2025},
journal = {ACBS},
doi = {10.1037/hea0001434},
url = {https://doi.org/10.1037/hea0001434}
}RIS
TY - JOUR TI - Intervention-related body shame and wellness in persons at risk for Type 2 diabetes; iACT + diabetes prevention education vs. education alone. N=298. Lipsett, M., & Berkman, E. (2025). A randomized controlled trial of an acceptance and commitment therapy-informed diabetes prevention program reduces AU - Lipsett, M. B. AU - Berkman, Elliot T. PY - 2025 PB - ACBS DO - 10.1037/hea0001434 UR - https://doi.org/10.1037/hea0001434 ER -
APA
Lipsett, M. B., & Berkman, E. T. (2025). Intervention-related body shame and wellness in persons at risk for Type 2 diabetes; iACT + diabetes prevention education vs. education alone. N=298. Lipsett, M., & Berkman, E. (2025). A randomized controlled trial of an acceptance and commitment therapy-informed diabetes prevention program reduces . ACBS. https://doi.org/10.1037/hea0001434
Related entries
- A Randomized Controlled Trial of Acceptance and Commitment Therapy for Type 2 Diabetes Management: The Moderating Role of Coping Styles
- Acceptance-based therapy: the potential to augment behavioral interventions in the treatment of type 2 diabetes
- Effectiveness of acceptance and commitment therapy in people with type 2 diabetes mellitus: A systematic review and meta‐analysis
- Efficacy of acceptance and commitment therapy for people with type 2 diabetes: Systematic review and meta‐analysis
- Disease adjustment in diabetes. ACT vs Diabetes Self-Care Management vs no additional treatment. N=60. Soltanian, N., Boogar, I. R., & Talepasand, S. (2022). Comparison of the Effectiveness of Acceptance and Commitment Therapy with Health-Promoting Lifestyle Intervention on Disease Perception and Ad
- Acceptance and commitment therapy (ACT) for adult type 1 diabetes management: study protocol for a randomised controlled trial
- Acceptance and Commitment Based Therapy on Disease Perception and Psychological Capital in Patients with Type II Diabetes
- The Effectiveness of Acceptance and Commitment Therapy (ACT) on Self-Efficacy, Perceived Stress and Resiliency in Type II Diabetes Patients
- A1c and self-management in diabetes; ACT vs TAU. N=81. Wijk, I., Amsberg, S., Johansson, U., Livheim, F., Toft, E. & Anderbro, T. (2023). Impact of an Acceptance and Commitment Therapy programme on HbA1c, self-management and psychosocial factors in adults with type 1 diabetes and elevated HbA1c leve
- The Effectiveness of Acceptance and Commitment Therapy on Quality of Life among Patients with Type 2 Diabetes